| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |